Advances in atheroma imaging in the carotid

Cerebrovascular Diseases

Volumn 24, Issue SUPPL. 1, 2007, Pages 40-48

  Gillard, Jonathan H ^a  

^a CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Atheroma; Computed tomography; Magnetic resonance imaging; Positron emission tomography

Indexed keywords

AORTA; ATHEROMA; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BRAIN BLOOD VESSEL; CARDIOVASCULAR RISK; CAROTID ARTERY; CAROTID ARTERY DISEASE; CAROTID ARTERY OBSTRUCTION; COMPUTATIONAL FLUID DYNAMICS; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONFERENCE PAPER; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; DEATH; DIAGNOSTIC IMAGING; DIGITAL SUBTRACTION ANGIOGRAPHY; FINITE ELEMENT ANALYSIS; HEART INFARCTION; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MORBIDITY; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PERIPHERAL CIRCULATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; STROKE; THROMBOSIS; ULTRASOUND;

ANGIOGRAPHY, DIGITAL SUBTRACTION; ATHEROSCLEROSIS; CAROTID ARTERY DISEASES; DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; POSITRON-EMISSION TOMOGRAPHY; ULTRASONOGRAPHY;

EID: 35648929264     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000107378     Document Type: Conference Paper

References (71)

1. Carr S, Farb A, Pearce WH, Virmani R, Yao JS: Atherosclerotic plaque rupture in symptomatic carotid artery stenosis. J Vasc Surg 1996;23:755-765, discussion 765-766.
2. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1991;325:445-453.
3. MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. European Carotid Surgery Trialists' Collaborative Group. Lancet 1991;337:1235-1243.
4. Endarterectomy for moderate symptomatic carotid stenosis: interim results from the MRC European Carotid Surgery Trial. Lancet 1996;347:1591-1593.
5. Halliday A, Mansfield A, Marro J, Peto C, Peto R, Potter J, et al: Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet 2004;363:1491-1502.
6. Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA 1995;273:1421-1428.
7. Gillard JH: Imaging of carotid artery disease: from luminology to function? Neuroradiology 2003;45:671-680.
8. Wasserman BA, Wityk RJ, Trout HH 3rd, Virmani R: Low-grade carotid stenosis: looking beyond the lumen with MRI. Stroke 2005;36:2504-2513.
9. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ: Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987;28:1371-1375.
10. Mann JM, Davies MJ: Vulnerable plaque. Relation of characteristics to degree of stenosis in human coronary arteries. Circulation 1996;94:928-931.
11. Nederkoorn PJ, Mali WT, Eikelboom BC, Elgersma OEH, Buskens E, Hunink MGM, et al: Preoperative diagnosis of carotid artery stenosis: accuracy of noninvasive testing. Stroke 2002;33:2003-2008.
12. Heiserman JE, Dean BL, Hodak JA, Flom RA, Bird CR, Drayer BP, et al: Neurologic complications of cerebral angiography. Am J Neuroradiol 1994;15:1401-1407.
13. U-King-Im JM, Hollingworth W, Trivedi RA, Cross JJ, Higgins NJ, Graves MJ, et al: Contrast-enhanced MR angiography vs intra-arterial digital subtraction angiography for carotid imaging: activity-based cost analysis. Eur Radiol 2004;14:730-735.
14. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1991;325:445-453.
15. Westwood ME, Kelly S, Berry E, Bamford JM, Gough MJ, Airey CM, et al: Use of magnetic resonance angiography to select candidates with recently symptomatic carotid stenosis for surgery: systematic review. BMJ 2002;324:198.
16. Cosottini M, Pingitore A, Puglioli M, Michelassi MC, Lupi G, Abbruzzese A, et al: Contrast-enhanced three-dimensional magnetic resonance angiography of atherosclerotic internal carotid stenosis as the noninvasive imaging modality in revascularization decision making. Stroke 2003;34:660-664.
17. U-King-Im JM, Trivedi RA, Graves MJ, Higgins NJ, Cross JJ, Tom BD, et al: Contrast-enhanced MR angiography for carotid disease: diagnostic and potential clinical impact. Neurology 2004;62:1282-1290.
18. Vieco PT: CT angiography of the carotid artery. Neuroimaging Clin N Am 1998;8:593-605.
19. Hunt JL, Fauirman R, Mitchell ME, Carpenter JP, Golden M, Khalapyan T, et al: Bone formation in carotid plaques. A clinicopathological study. Stroke 2002;33:1214-1219.
20. Koelemay MJ, Nederkoorn PJ, Reitsma JB, Majoie CB: Systematic review of computed tomographic angiography for assessment of carotid artery disease. Stroke 2004;35:2306-2312.
21. Walker LJ, Ismail A, McMeekin W, Lambert D, Mendelow AD, Birchall D: Computed tomography angiography for the evaluation of carotid atherosclerotic plaque. Correlation with histopathology of endarterectomy specimens. Stroke 2002;33:977-981.
22. Gray-Weale AC, Graham JC, Burnett JR, Byrne K, Lusby RJ: Carotid artery atheroma: comparison of preoperative B-mode ultrasound appearance with carotid endarterectomy specimen pathology. J Cardiovasc Surg (Torino) 1988;29:676-681.
23. Tegos TJ, Kalomiris KJ, Sabetai MM, Kalodiki E, Nicolaides AN: Significance of sonographic tissue and surface characteristics of carotid plaques. Am J Neuroradiol 2001;22:1605-1612.
24. Lammie GA, Wardlaw J, Allan P, Ruckley CV, Peek R, Signorini DF: What pathological components indicate carotid atheroma activity and can these be identified reliably using ultrasound? Eur J Ultrasound 2000;11:77-86.
25. Lennihan L, Kupsky WJ, Mohr JP, Hauser WA, Correll JW, Quest DO: Lack of association between carotid plaque hematoma and ischemic cerebral symptoms. Stroke 1987;18:879-881.
26. Comerota AJ, Katz ML, White JV, Grosh JD: The preoperative diagnosis of the ulcerated carotid atheroma. J Vasc Surg 1990;11:505-510.
27. Hosomi N, Mizushige K, Ohuyama H, Takahashi T, Kitadai M, Hatanaka Y, et al: Angiotensin-converting enzyme inhibition with enalapril slows progressive intima-media thickening of the common carotid artery in patients with non-insulin dependent diabetes mellitus. Stroke 2001;32:1539-1545.
28. Nissen SE, Nicholls SJ, Sipahi I, Libby P, Raichlen JS, Ballantyne CM, et al: Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA 2006;295:1556-1565.
29. Yuan C, Murakami JW, Hayes CE, Tsuruda JS, Hatsukami TS, Wildy KS, et al: Phased-array magnetic resonance imaging of the carotid bifurcation: preliminary results in healthy volunteers and in a patient with atherosclerotic disease. J Magn Reson Imaging 1995;5:561-565.
30. Yuan C, Lin E, Millard J, Hwang J-N: Closed contour edge detection of black blood vessel lumen and outer wall boundaries in blackblood MR images. Magn Reson Imaging 1999;17:257-266.
31. Yuan C, Kerwin WS: MRI of atherosclerosis. J Magn Reson Imaging 2004;19:710-719.
32. Toussaint J-F, LaMuraglia GM, Southern JF, Fuster V, Kantor HL: Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo. Circulation 1996;94:932-938.
33. Fayad ZA, Fuster V: Characterization of atherosclerotic plaques by magnetic resonance imaging. Ann NY Acad Sci 2000;902:173-186.
34. Takaya N, Yuan C, Chu B, Saam T, Polissar NL, Jarvik GP, et al: Presence of intraplaque hemorrhage stimulates progression of carotid atherosclerotic plaques: a high-resolution magnetic resonance imaging study. Circulation 2005;111:2768-2775.
35. Saam T, Ferguson MS, Yarnykh VL, Takaya N, Xu D, Polissar NL, et al: Quantitative evaluation of carotid plaque composition by in vivo MRI. Arterioscler Thromb Vasc Biol 2005;25:234-239.
36. Trivedi RA, U-King-Im J, Graves MJ, Horsley J, Goddard M, Kirkpatrick PJ, et al: Multisequence in vivo MRI can quantify fibrous cap and lipid core components in human carotid atherosclerotic plaques. Eur J Vasc Endovasc Surg 2004;28:207-213.
37. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, et al: From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies. Part I. Circulation 2003;108:1664-1672.
38. Libby P, Geng YJ, Aikawa M, Schoenbeck U, Mach F, Clinton SK, et al: Macrophages and atherosclerotic plaque stability. Curr Opin Lipidol 1996;7:330-335.
39. Ross R: Atherosclerosis - an inflammatory disease. N Engl J Med 1999;340:115-126.
40. Vallabhajosula S, Fuster V: Atherosclerosis: imaging techniques and the evolving role of nuclear medicine. J Nucl Med 1997;38:1788-1796.
41. Vallabhajosula S: Radioisotropic imaging of atheroma;in Fuster V (ed): The Vulnerable Atherosclerotic Plaque: Understanding, Identification, and Modification. Armonk, Futurea Publishing Co, 1999, pp 213-229.
42. 18F]- fluorodeoxyglucose positron emission tomography. Circulation 2002;105:2708-2711.
43. 18F fluorodeoxyglucose positron-emission tomography and high-resolution magnetic resonance imaging. Stroke 2005;36:2642-2647.
44. Mack MG, Balzer JO, Straub R, Eichler K, Vogl TJ: Superparamagnetic iron oxide-enhanced MR imaging of head and neck lymph nodes. Radiology 2002;222:239-244.
45. Ruehm SG, Corot C, Vogt P, Kolb S, Debatin JF: Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation 2001;103:415-422.
46. Schmitz SA, Taupitz M, Wagner S, Coupland SE, Gust R, Nikolova A, et al: Iron-oxide-enhanced magnetic resonance imaging of atherosclerotic plaques. Postmortem analysis of accuracy, inter-observer agreement, and pitfalls. Invest Radiol 2002;37:405-411.
47. Trivedi RA, U-King-Im JM, Graves MJ, Cross JJ, Horsley J, Goddard MJ, et al: In vivo detection of macrophages in human carotid atheroma: temporal dependence of ultrasmall superparamagnetic particles of iron oxide-enhanced MRI. Stroke 2004;35:1631-1635.
48. Trivedi RA, Mallawarachi C, U-King-Im JM, Graves MJ, Horsley J, Goddard MJ, et al: Identifying inflamed carotid plaques using in vivo USPIO-enhanced MR imaging to label plaque macrophages. Arterioscler Thromb Vasc Biol 2006;26:1601-1606.
49. Kooi ME, Cappendijk VC, Cleutjens KBJM, Kessels AGH, Kitslaar PJEHM, Borgers M, et al: Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation 2003;107:2453-2458.
50. Loree HM, Kamm RD, Stringfellow RG, Lee RT: Effects of fibrous cap thickness on peak circumferential stress in model atherosclerotic vessels. Circ Res 1992;71:850-858.
51. Cheng GC, Loree HM, Kamm RD, Fishbein MC, Lee RT: Distribution of circumferential stress in ruptured and stable atherosclerotic lesions. A structural analysis with histopathological correlation. Circulation 1993;87:1179-1187.
52. Li ZY, Howarth S, Trivedi RA, U-King-Im JM, Graves MJ, Brown A, et al: Stress analysis of carotid plaque rupture based on in vivo high resolution MRI. J Biomech 2006;39:2611-2622.
53. Li ZY, Howarth SP, Tang T, Gillard JH: How critical is fibrous cap thickness to carotid plaque stability? A flow-plaque interaction model. Stroke 2006;37:1195-1199.
54. Caro CG, Fitz-Gerald JM, Schroter RC: Arterial wall shear and distribution of early atheroma in man. Nature 1969;223:1159-1160.
55. Zhao SZ, Ariff B, Long Q, Hughes AD, Thom SA, Stanton AV, et al: Inter-individual variations in wall shear stress and mechanical stress distributions at the carotid artery bifurcation of healthy humans. J Biomech 2002;35:1367-1377.
56. Sankatsing RR, de Groot E, Jukema JW, de Feyter PJ, Pennell DJ, Schoenhagen P, et al: Surrogate markers for atherosclerotic disease. Curr Opin Lipidol 2005;16:434-441.
57. Crisby M, Nordin-Fredriksson G, Shah PK, Yano J, Zhu J, Nilsson J: Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques. Implications for plaque stabilization. Circulation 2001;103:926-933.
58. Thies F, Garry JMC, Yaqoob P, Rerkasem K, Williams JL, Shearman CP, et al: Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet 2003;361:477-485.
59. Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS). Lancet 1994;344:633-638.
60. Jukema JW, Bruschke AVG, van Boven J, Reiber JHC, Bal ET, Zwinderman AH, et al: Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS). Circulation 1995;91:2528-2540.
61. Pitt B, Mancini GBJ, Ellis SG, Rosman HS, Park J-S, McGovern ME: Pravastatin limitation of atherosclerosis in coronary arteries (PLAC I): reduction in atherosclerosis progression and clinical events. J Am Coll Cardiol 1995;26:1133-1139.
62. Hodis HN, Mack WJ, LaBree L, Selzer RH, Liu CR, Liu CH, et al: The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med 1998;128:262-269.
63. Nissen SE, Tuzcu EM, Schoenhagen P, Brown BG, Ganz P, Vogel RA, et al: Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA 2004;291:1071-1080.
64. Helft G, Worthley SG, Fuster V, Fayad ZA, Zaman AG, Corti R, et al: Progression and regression of atherosclerotic lesions. Monitoring with serial noninvasive magnetic resonance imaging. Circulation 2002;105:993-998.
65. Zhao X-Q, Yuan C, Hatsukami TS, Frechette EH, Kang X-J, Maravilla KR, et al: Effects of prolonged intensive lipid-lowering therapy on the characteristics of carotid atherosclerotic plaques in vivo by MRI. A case-control study. Arterioscler Thromb Vasc Biol 2001;21:1623-1629.
66. Corti R, Fayad ZA, Fuster V, Worthley SG, Helft G, Chesebro J, et al: Effects of lipid-lowering by simvastatin on human atherosclerotic lesions. A longitudinal study of highresolution, noninvasive magnetic resonance imaging. Circulation 2001;104:249-252.
67. Corti R, Fuster V, Fayad ZA, Worthley SG, Helft G, Chaplin WF, et al: Effects of aggressive versus conventional lipid-lowering therapy by simvastatin on human atherosclerotic lesions: a prospective, randomized, double-blind trial with high-resolution magnetic resonance imaging. J Am Coll Cardiol 2005;46:106-112.
68. Villanueva FS, Wagner WR, Vannan MA, Narula J: Targeted ultrasound imaging using microbubbles. Cardiol Clin 2004;22:283-298, vii.
69. Choudhury RP, Fuster V, Fayad ZA: Molecular, cellular and functional imaging of atherothrombosis. Nat Rev Drug Discov 2004;3:913-925.
70. Bhatia V, Bhatia R, Dhindsa S, Dhindsa M: Imaging of the vulnerable plaque: new modalities. South Med J 2003;96:1142-1147.
71. Moselewski F, Ropers D, Pohle K, Hoffmann U, Ferencik M, Chan RC, et al: Comparison of measurement of cross-sectional coronary atherosclerotic plaque and vessel areas by 16-slice multidetector computed tomography versus intravascular ultrasound. Am J Cardiol 2004;94:1294-1297.